These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16650489)

  • 1. Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses.
    Naesens L; Stephens CE; Andrei G; Loregian A; De Bolle L; Snoeck R; Sowell JW; De Clercq E
    Antiviral Res; 2006 Oct; 72(1):60-7. PubMed ID: 16650489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
    Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
    Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In search of effective anti-HHV-6 agents.
    De Clercq E; Naesens L
    J Clin Virol; 2006 Dec; 37 Suppl 1():S82-6. PubMed ID: 17276375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts.
    Naesens L; Bonnafous P; Agut H; De Clercq E
    J Clin Virol; 2006 Dec; 37 Suppl 1():S69-75. PubMed ID: 17276373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
    de Castro S; Peromingo MT; Naesens L; Andrei G; Snoeck R; Balzarini J; Velázquez S; Camarasa MJ
    J Med Chem; 2008 Sep; 51(18):5823-32. PubMed ID: 18707089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance.
    De Bolle L; Manichanh C; Agut H; De Clercq E; Naesens L
    Antiviral Res; 2004 Oct; 64(1):17-25. PubMed ID: 15451175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective anti-cytomegalovirus compounds discovered by screening for inhibitors of subunit interactions of the viral polymerase.
    Loregian A; Coen DM
    Chem Biol; 2006 Feb; 13(2):191-200. PubMed ID: 16492567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
    Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423.
    De Bolle L; Andrei G; Snoeck R; Zhang Y; Van Lommel A; Otto M; Bousseau A; Roy C; De Clercq E; Naesens L
    Biochem Pharmacol; 2004 Jan; 67(2):325-36. PubMed ID: 14698045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.
    Ducancelle A; Alain S; Petit F; Sanson Le Pors MJ; Mazeron MC
    J Virol Methods; 2007 May; 141(2):212-5. PubMed ID: 17197042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells.
    Michaelis M; Ha TA; Doerr HW; Cinatl J
    Cardiovasc Res; 2008 Feb; 77(3):544-50. PubMed ID: 18006438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study on the action of allitridin against human cytomegalovirus in vitro: Inhibitory effects on immediate-early genes.
    Zhen H; Fang F; Ye DY; Shu SN; Zhou YF; Dong YS; Nie XC; Li G
    Antiviral Res; 2006 Oct; 72(1):68-74. PubMed ID: 16844239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR.
    Schnepf N; Boiteau N; Petit F; Alain S; Sanson-Le Pors MJ; Mazeron MC
    Antiviral Res; 2009 Jan; 81(1):64-7. PubMed ID: 18992772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
    De Castro S; García-Aparicio C; Andrei G; Snoeck R; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2009 Mar; 52(6):1582-91. PubMed ID: 19226140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human herpesvirus 6 ganciclovir-resistant strain with amino acid substitutions associated with the death of an allogeneic stem cell transplant recipient.
    Isegawa Y; Hara J; Amo K; Osugi Y; Takemoto M; Yamanishi K; Fukunaga R; Shibata M; Ohshima A; Horiguchi Y; Sugimoto N
    J Clin Virol; 2009 Jan; 44(1):15-9. PubMed ID: 18952495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human herpesvirus 6 (HHV-6) U94/REP protein inhibits betaherpesvirus replication.
    Caselli E; Bracci A; Galvan M; Boni M; Rotola A; Bergamini C; Cermelli C; Dal Monte P; Gompels UA; Cassai E; Di Luca D
    Virology; 2006 Mar; 346(2):402-14. PubMed ID: 16368124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity evaluation of Parkia pendula seed lectin against human cytomegalovirus and herpes virus 6.
    Favacho AR; Cintra EA; Coelho LC; Linhares MI
    Biologicals; 2007 Jun; 35(3):189-94. PubMed ID: 17254798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of 6 or 8-substitution on the antiviral activity of 3-phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV).
    Véron JB; Enguehard-Gueiffier C; Snoeck R; Andrei G; De Clercq E; Gueiffier A
    Bioorg Med Chem; 2007 Nov; 15(22):7209-19. PubMed ID: 17869124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.